Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v2.4.0.6
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues        
Product $ 3,890 $ 3,296 $ 7,674 $ 5,911
Product licensing fees 374 94 406 189
Service 262 273 497 503
Total revenues 4,526 3,663 8,577 6,603
Cost of revenues        
Product 1,092 668 2,080 1,458
Service 234 217 413 418
Total cost of revenues 1,326 885 2,493 1,876
Gross profit 3,200 2,778 6,084 4,727
Operating expenses        
Research and development 513 560 1,045 996
Selling, general and administrative 3,504 2,848 6,351 6,379
Total operating expenses 4,017 3,408 7,396 7,375
Loss from operations (817) (630) (1,312) (2,648)
Interest expense (280) (230) (568) (392)
Interest income 1 1 2 2
(Loss) gain due to change in fair value of derivative instruments (397) 121 850 218
Other expense, net (26) (101) (46) (194)
Net loss (1,519) (839) (1,074) (3,014)
Preferred stock deemed dividend       (1,062)   
Net loss available to common shareholders (1,519) (839) (2,136) (3,014)
Net loss per common share: basic and diluted (in Dollars per share) $ (0.05) $ (0.03) $ (0.07) $ (0.11)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted (in Shares) 32,616 26,828 32,111 26,771
Other comprehensive loss, net of tax        
Net loss (1,519) (839) (1,074) (3,014)
Foreign currency translation adjustments 119 (174) (1) (207)
Other comprehensive loss $ (1,400) $ (1,013) $ (1,075) $ (3,221)